Lv1
30 积分 2022-11-01 加入
Nanoliposomal irinotecan and fluorouracil plus leucovorin versus fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies (AIO NALIRICC): a multicentre, open-label, randomised, phase 2 trial
9天前
已完结
Second-line liposomal irinotecan plus fluorouracil and leucovorin in metastatic biliary tract cancer – Author's reply
9天前
已完结
Second-line liposomal irinotecan plus fluorouracil and leucovorin in metastatic biliary tract cancer
9天前
已完结
Is There Room for Liposomal Irinotecan in Biliary Tract Cancer? A Meta-analysis of Randomised Trials
10天前
已完结
Safety and efficacy of liposomal irinotecan as the second-line treatment for advanced pancreatic cancer: A systematic review and meta-analysis
10天前
已完结
A Stable Irinotecan Liposome with Enhanced Antitumor Activity in a Range of Tumor Models
13天前
已完结
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
18天前
已完结
Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial
22天前
已完结
Preoperative chemotherapy prior to primary tumour resection for asymptomatic synchronous unresectable colorectal liver-limited metastases: The RECUT multicenter randomised controlled trial
22天前
已完结
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer
29天前
已完结
皖公网安备34019202002308
